Cellular Immune Responses in Asymptomatic Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Effects of Vaccination with Recombinant Envelope Glycoprotein of HIV-1

Por Gorse, Geoffrey J., Simionescu, Ramona E., Patel, Gira B.
Publicado em 2006

1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age

Por Gorse, Geoffrey J., Falsey, Ann, Landolfi, Victoria, Ozol-Godfrey, Ayca, Tsang, Peter
Publicado no Open Forum Infect Dis (2014)

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Por Gorse, Geoffrey J., Patel, Gira B., Vitale, Joseph N., O'Connor, Theresa Z.
Publicado em 2010

Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemaggl...

Por Gorse, Geoffrey J, Grimes, Stephen, Buck, Helen, Mulla, Hussain, White, Peter, Graham, Irene, Treanor, John J, Hill, Heather, May, Jeanine, Blackburn, Peter
Publicado no Open Forum Infect Dis (2017)

DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immu...

Por Gorse, Geoffrey J., Newman, Mark J., deCamp, Allan, Hay, Christine Mhorag, De Rosa, Stephen C., Noonan, Elizabeth, Livingston, Brian D., Fuchs, Jonathan D., Kalams, Spyros A., Cassis-Ghavami, Farah L.
Publicado em 2012

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in he...

Por Radonovich, Lewis J., Bessesen, Mary T., Cummings, Derek A., Eagan, Aaron, Gaydos, Charlotte, Gibert, Cynthia, Gorse, Geoffrey J., Nyquist, Ann-Christine, Reich, Nicholas G., Rodrigues-Barradas, Maria, Savor-Price, Connie, Shaffer, Ronald E., Simberkoff, Michael S., Perl, Trish M.
Publicado no BMC Infect Dis (2016)

Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult P...

Por Frey, Sharon E., Peiperl, Laurence, McElrath, M. Juliana, Kalams, Spyros, Goepfert, Paul A., Keefer, Michael C., Baden, Lindsey R., Lally, Michelle A., Mayer, Kenneth, Blattner, William A., Harro, Clayton D., Hammer, Scott M., Gorse, Geoffrey J., Hural, John, Tomaras, Georgia D., Levy, Yves, Gilbert, Peter, deCamp, Allan, Russell, Nina D., Elizaga, Marnie, Allen, Mary, Corey, Lawrence
Publicado no Clin Vaccine Immunol (2014)